TD BUY $VIAV at 12.52, Supp 12.52 Resis 13.75 R10 HiLo 69% T1Y 15 buy 2.0 fwdPE 17.9 DIV N/A #Viavi Solu #stocks #trading #finance #market

2019-05-22
71 Views

TD BUY detected for VIAV (Viavi Solutions Inc.) at the close price of 12.52 with a support level at 12.52 and a resistance at 13.75, providing an opportunity for a 10 % return. Trading at a 69 % level between the 52week High (14.00) and 52 week Low (9.17). The average analyst 1-year target price is 15.0 with an average buy and a score of 2.0.

TD Buy
10 %
VIAV
12.52
Viavi Solutions Inc.
HiLo
69.4 %
Support
12.52
Resistance
13.75
Target1Y
15.00
Rated
buy
Score
2.0
52week high
14.00
52week low
9.17
50DMA
12.80
200DMA
11.53
10DMA
13.16
20DMA
13.28
100DMA
12.13
Volume
2646239
AvgDayVol
2209367
MarketCap
2863148800
EBITDA
176300000
Revenue
1106000000
PE
0.00
P2S
2.59
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
13 views
Bull, Europe, Germany
13 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
9 views
Bear, Europe, Financial Services
9 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.